Page last updated: 2024-08-22

technetium and Carcinoma in Situ

technetium has been researched along with Carcinoma in Situ in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baum, RP; Borrón, M; Díaz, N; Oliva, JP; Oliver, B; Ortiz, R; Peralta, R; Pimentel, G; Sánchez, I; Vázquez, AM1

Trials

1 trial(s) available for technetium and Carcinoma in Situ

ArticleYear
[Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer].
    Revista espanola de medicina nuclear, 2001, Volume: 20, Issue:4

    Topics: Adenocarcinoma; Adenoma; Adult; Aged; Animals; Antibodies, Heterophile; Antibodies, Monoclonal; Antigens, Neoplasm; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma in Situ; Colorectal Neoplasms; Epitopes; Female; Humans; Immunoconjugates; Immunoglobulin G; Male; Mice; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radioimmunodetection; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon

2001